Communication
Version 1
Preserved in Portico This version is not peer-reviewed
Cold Atmospheric Plasma for COVID-19
*
and
Version 1
: Received: 7 April 2020 / Approved: 8 April 2020 / Online: 8 April 2020 (11:34:11 CEST)
How to cite: Chen, Z.; Wirz, R. Cold Atmospheric Plasma for COVID-19. Preprints 2020, 2020040126. https://doi.org/10.20944/preprints202004.0126.v1 Chen, Z.; Wirz, R. Cold Atmospheric Plasma for COVID-19. Preprints 2020, 2020040126. https://doi.org/10.20944/preprints202004.0126.v1
Abstract
The recent pandemic has greatly stressed supply chains, treatment modalities, and medical resources. Cold atmospheric plasma (CAP) has been used for a wide range of applications in biomedical engineering due to its many components including electrons, charged particles, reactive oxygen species (ROS), reactive nitrogen species (RNS), free radicals, ultraviolet (UV) photons, molecules, electromagnetic fields, physical forces, and electric fields. In this manuscript, we develop CAP devices for COVID-19. Our manuscript indicates the advantages of highlydeployable CAP devices for both sanitation and treatment, without the need for supply chains of special consumables such as hand sanitizers and the like. We hope that this timely research will help engage the broader community of engineers that wish to help the medical community with this pandemic and to prevent and treat future outbreaks.
Keywords
Cold atmospheric Plasma; sterilization; Plasma-activated medium; Nitric oxide; Immunotherapy; COVID-19
Subject
Biology and Life Sciences, Biophysics
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
